ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 561,13
1,09%
Dow Jones
39 169,52
0,13%
DAX
18 290,66
0,31%
Brent Oil
86,60
0,08%
Bitcoin
62 809,10
-0,06%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) Actualités

PSTV

Plus Therapeutics (PSTV)

Plus Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PSTV
DateHeureSourceTitreSymboleSociété
07/06/202423h02Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PSTVPlus Therapeutics Inc
07/06/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
07/06/202413h30GlobeNewswire Inc.Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRITNASDAQ:PSTVPlus Therapeutics Inc
05/06/202413h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSTVPlus Therapeutics Inc
17/05/202423h00GlobeNewswire Inc.Plus Therapeutics Announces New Employment Inducement GrantsNASDAQ:PSTVPlus Therapeutics Inc
15/05/202422h15GlobeNewswire Inc.Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
15/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTVPlus Therapeutics Inc
13/05/202413h30GlobeNewswire Inc.Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024NASDAQ:PSTVPlus Therapeutics Inc
10/05/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/05/202417h29GlobeNewswire Inc.Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE TrialNASDAQ:PSTVPlus Therapeutics Inc
08/05/202423h35GlobeNewswire Inc.Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE TrialNASDAQ:PSTVPlus Therapeutics Inc
06/05/202413h30GlobeNewswire Inc.Plus Therapeutics Announces Private Placement Financing of up to $18 MillionNASDAQ:PSTVPlus Therapeutics Inc
22/04/202413h00GlobeNewswire Inc.Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of DefenseNASDAQ:PSTVPlus Therapeutics Inc
08/03/202422h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PSTVPlus Therapeutics Inc
05/03/202422h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PSTVPlus Therapeutics Inc
22/11/202322h22Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
21/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSTVPlus Therapeutics Inc
11/09/202313h00GlobeNewswire Inc.Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/09/202313h00GlobeNewswire Inc.Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration AssayNASDAQ:PSTVPlus Therapeutics Inc
05/09/202313h00GlobeNewswire Inc.Plus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a Trial for Leptomeningeal MetastaseNASDAQ:PSTVPlus Therapeutics Inc
30/08/202313h00GlobeNewswire Inc.Plus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PSTVPlus Therapeutics Inc
14/08/202322h05GlobeNewswire Inc.Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
11/08/202312h30GlobeNewswire Inc.Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at the 2023 SNO/ASCO CNS Cancer ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/08/202322h05GlobeNewswire Inc.Plus Therapeutics to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 14, 2023NASDAQ:PSTVPlus Therapeutics Inc
08/08/202317h22GlobeNewswire Inc.Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer ConferenceNASDAQ:PSTVPlus Therapeutics Inc
03/08/202313h00GlobeNewswire Inc.Plus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:PSTVPlus Therapeutics Inc
27/07/202322h05GlobeNewswire Inc.Plus Therapeutics Strengthens Clinical Program with the Appointment of Pius Maliakal as Vice President of Clinical OperationsNASDAQ:PSTVPlus Therapeutics Inc
27/07/202313h00GlobeNewswire Inc.Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer ConferenceNASDAQ:PSTVPlus Therapeutics Inc
13/07/202313h00GlobeNewswire Inc.Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals SummitNASDAQ:PSTVPlus Therapeutics Inc
29/06/202313h00GlobeNewswire Inc.Plus Therapeutics Reports Positive Interim Updates from Two ReSPECT™ Clinical Trials at SNMMI Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTV

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
COIN
ETHUSD
Ethereum
EU
ORA
Orange
EU
GLE
Societe Generale
EU
RI
Pernod Ricard
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
EU
VK
Vallourec
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés